申请人:Wood R. Michael
公开号:US20060122236A1
公开(公告)日:2006-06-08
Substituted biaryl carboxylate derivatives are bradykinin B1 antagonists or inverse agonists useful in the treatment or prevention of symptoms such as pain and inflammation associated with the bradykinin B1 pathway.
取代的联苯羧酸酯衍生物是布雷金肽B1拮抗剂或逆激动剂,可用于治疗或预防与布雷金肽B1途径相关的疼痛和炎症症状。